CHCHD4 and pulmonary arterial hypertension: In current study, we demonstrated that CHCHD4 elevation orchestrates mitochondrial oxidative phosphorylation and antagonizes aberrant proliferation and migration of PASMCs, thereby disturbing hypoxic PAH, which could be a novel target for PAH treatment.